Janux Therapeutics (JANX) EPS (Basic): 2020-2025
Historic EPS (Basic) for Janux Therapeutics (JANX) over the last 6 years, with Sep 2025 value amounting to -$0.39.
- Janux Therapeutics' EPS (Basic) rose 23.53% to -$0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.67, marking a year-over-year decrease of 43.97%. This contributed to the annual value of -$1.28 for FY2024, which is 3.03% up from last year.
- As of Q3 2025, Janux Therapeutics' EPS (Basic) stood at -$0.39, which was up 29.09% from -$0.55 recorded in Q2 2025.
- Janux Therapeutics' EPS (Basic)'s 5-year high stood at -$0.11 during Q2 2024, with a 5-year trough of -$2.06 in Q1 2021.
- Over the past 3 years, Janux Therapeutics' median EPS (Basic) value was -$0.38 (recorded in 2025), while the average stood at -$0.36.
- In the last 5 years, Janux Therapeutics' EPS (Basic) skyrocketed by 84.47% in 2022 and then slumped by 400.00% in 2025.
- Quarterly analysis of 5 years shows Janux Therapeutics' EPS (Basic) stood at -$0.29 in 2021, then slumped by 34.48% to -$0.39 in 2022, then surged by 38.46% to -$0.24 in 2023, then plummeted by 45.83% to -$0.35 in 2024, then climbed by 23.53% to -$0.39 in 2025.
- Its last three reported values are -$0.39 in Q3 2025, -$0.55 for Q2 2025, and -$0.38 during Q1 2025.